Correlation Between Cytokinetics and Stoke Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cytokinetics and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytokinetics and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cytokinetics and Stoke Therapeutics, you can compare the effects of market volatilities on Cytokinetics and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytokinetics with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytokinetics and Stoke Therapeutics.

Diversification Opportunities for Cytokinetics and Stoke Therapeutics

0.6

Correlation Coefficient

Cytokinetics  Stoke Therapeutics

Poor diversification

The 3 months correlation between Cytokinetics and Stoke is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Cytokinetics and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Cytokinetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytokinetics are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Cytokinetics i.e., Cytokinetics and Stoke Therapeutics go up and down completely randomly.

Pair Corralation between Cytokinetics and Stoke Therapeutics

Given the investment horizon of 90 days Cytokinetics is expected to generate 0.69 times more return on investment than Stoke Therapeutics. However, Cytokinetics is 1.44 times less risky than Stoke Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Stoke Therapeutics is currently generating about -0.09 per unit of risk. If you would invest  5,489  in Cytokinetics on September 4, 2024 and sell it today you would lose (426.00) from holding Cytokinetics or give up 7.76% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Cytokinetics  vs.  Stoke Therapeutics

Cytokinetics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cytokinetics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Cytokinetics is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Stoke Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Stoke Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Cytokinetics and Stoke Therapeutics

The main advantage of trading using opposite Cytokinetics and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytokinetics position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.

The idea behind Cytokinetics and Stoke Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.